Evelyn Partners Investment Management Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.23M Buy
8,949
+1,450
+19% +$1.47M 0.97% 28
2025
Q4
$8.06M Buy
7,499
+211
+3% +$202K 1.01% 29
2025
Q3
$5.56M Buy
7,288
+5,699
+359% +$4.24M 0.75% 38
2025
Q2
$1.24M Sell
1,589
-707
-31% -$549K 0.19% 70
2025
Q1
$1.9M Buy
2,296
+1,479
+181% +$1.23M 0.31% 57
2024
Q4
$631K Buy
+817
New +$676K 0.11% 83

Other funds holding LLY

Evelyn Partners Investment Management Services's LLY Position: Q1 2026 in Review

Evelyn Partners Investment Management Services increased its Eli Lilly (LLY) stake by 19% in Q1 2026, buying an estimated $1.47M and bringing the position to 8,949 shares worth $8.23M. The position accounts for 0.97% of the portfolio, ranked #28.

Evelyn Partners Investment Management Services first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Evelyn Partners Investment Management Services held 8,949 shares of Eli Lilly worth $8.23M as of Q1 2026.
  • Evelyn Partners Investment Management Services bought 1,450 Eli Lilly shares in Q1 2026, an estimated $1.47M.
  • Eli Lilly made up 0.97% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #28 holding.
  • Evelyn Partners Investment Management Services first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.